Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population
Dr Ed Pavlik talks to ecancer at the 2012 International Gynaecologic Cancer Society meeting in Vancouver about the importance and methods for ovarian cancer screening.
The early detection method, transvaginal ultrasound, allows for a diagnosis of 70 percent of stage one and two cases. Ovarian cancer has seven times less prevalence than breast cancer, but a 60 percent mortality rate if not detected in these early stages
The method of transvaginal ultrasound uses serial screenings to compare structures to a number index and morphology index that detects abnormalities and monitors them over time.
Dr Pavlik notes that most abnormalities resolve themselves, but this monitoring initiates immediate actions when required and prevents false positives.
Filming supported by Amgen
Blood-based test may provide a convenient and effective option for CRC screening in the average-risk U.S. population
New classification for identifying HR myeloma based on cytogenetic abnormalities
Best practice in HRRm testing in patients with metastatic prostate cancer
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Community-based breast cancer control programme in the Philipines
Initiatives for cancer control in Indonesia
PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo
Choosing Wisely in radiology Tanzania
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery